116 related articles for article (PubMed ID: 23959946)
1. Detection of high-risk human papillomaviruses in fresh breast cancer samples using the hybrid capture 2 assay.
Liang W; Wang J; Wang C; Lv Y; Gao H; Zhang K; Liu H; Feng J; Wang L; Ma R
J Med Virol; 2013 Dec; 85(12):2087-92. PubMed ID: 23959946
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a multiplex real time PCR assay for the detection of human papillomavirus infections on self-collected cervicovaginal lavage samples.
Jentschke M; Soergel P; Hillemanns P
J Virol Methods; 2013 Oct; 193(1):131-4. PubMed ID: 23707925
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women.
Lindel K; Forster A; Altermatt HJ; Greiner R; Gruber G
Breast; 2007 Apr; 16(2):172-7. PubMed ID: 17088061
[TBL] [Abstract][Full Text] [Related]
4. No evidence of human papillomavirus DNA sequences in invasive breast carcinoma.
de Cremoux P; Thioux M; Lebigot I; Sigal-Zafrani B; Salmon R; Sastre-Garau X;
Breast Cancer Res Treat; 2008 May; 109(1):55-8. PubMed ID: 17624590
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and type distribution of high-risk human papillomavirus infection in women undergoing voluntary cervical cancer screening in Italy.
Agarossi A; Ferrazzi E; Parazzini F; Perno CF; Ghisoni L
J Med Virol; 2009 Mar; 81(3):529-35. PubMed ID: 19152401
[TBL] [Abstract][Full Text] [Related]
6. Validation of ThermoFisher's Papspin for human papillomavirus detection in cervicovaginal specimens using PCR with GP5+/GP6+ primers and the Hybrid Capture II assay.
Weynand B; Delvenne P; Polet R; Guiot Y; Arafa M; Somja J; Galant C
Clin Microbiol Infect; 2010 Jun; 16(6):671-5. PubMed ID: 19689463
[TBL] [Abstract][Full Text] [Related]
7. High-risk human papilloma virus infection, tumor pathophenotypes, and BRCA1/2 and TP53 status in juvenile breast cancer.
Aceto GM; Solano AR; Neuman MI; Veschi S; Morgano A; Malatesta S; Chacon RD; Pupareli C; Lombardi M; Battista P; Marchetti A; Mariani-Costantini R; Podestà EJ
Breast Cancer Res Treat; 2010 Aug; 122(3):671-83. PubMed ID: 19851859
[TBL] [Abstract][Full Text] [Related]
8. Comparison of INNO-LiPA genotyping extra and hybrid capture 2 assays for detection of carcinogenic human papillomavirus genotypes.
Barzon L; Militello V; Pagni S; Palù G
J Clin Virol; 2012 Nov; 55(3):256-61. PubMed ID: 22877561
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study.
Iftner T; Eberle S; Iftner A; Holz B; Banik N; Quint W; Straube AN
J Med Virol; 2010 Nov; 82(11):1928-39. PubMed ID: 20872721
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of EBV, HPV and MMTV in Pakistani breast cancer patients: A possible etiological role of viruses in breast cancer.
Naushad W; Surriya O; Sadia H
Infect Genet Evol; 2017 Oct; 54():230-237. PubMed ID: 28705719
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens.
Gupta A; Arora R; Gupta S; Prusty BK; Kailash U; Batra S; Das BC
J Clin Virol; 2006 Nov; 37(3):190-4. PubMed ID: 16931139
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: the CLEOPATRE study.
Castellsagué X; Iftner T; Roura E; Vidart JA; Kjaer SK; Bosch FX; Muñoz N; Palacios S; San Martin Rodriguez M; Serradell L; Torcel-Pagnon L; Cortes J;
J Med Virol; 2012 Jun; 84(6):947-56. PubMed ID: 22499018
[TBL] [Abstract][Full Text] [Related]
14. Almost Complete Lack of Human Cytomegalovirus and Human papillomaviruses Genome in Benign and Malignant Breast Lesions in Shiraz, Southwest of Iran.
Bakhtiyrizadeh S; Hosseini SY; Yaghobi R; Safaei A; Sarvari J
Asian Pac J Cancer Prev; 2017 Dec; 18(12):3319-3324. PubMed ID: 29286226
[TBL] [Abstract][Full Text] [Related]
15. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
16. Hypothetic association between human papillomavirus infection and breast carcinoma.
Liang W; Tian H
Med Hypotheses; 2008; 70(2):305-7. PubMed ID: 17656036
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
Didelot MN; Boulle N; Damay A; Costes V; Segondy M
J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus DNA detection in male sexual partners of women with genital human papillomavirus infection.
Nicolau SM; Camargo CG; Stávale JN; Castelo A; Dôres GB; Lörincz A; de Lima GR
Urology; 2005 Feb; 65(2):251-5. PubMed ID: 15708032
[TBL] [Abstract][Full Text] [Related]
19. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of human papillomaviruses in fresh frozen breast cancer samples.
Antonsson A; Spurr TP; Chen AC; Francis GD; McMillan NA; Saunders NA; Law M; Bennett IC
J Med Virol; 2011 Dec; 83(12):2157-63. PubMed ID: 22012724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
